Stephen Kennedy
Chief Tech/Sci/R&D Officer chez CRISPR THERAPEUTICS AG
Profil
Stephen R. Kennedy occupe le poste de Head-Technical Operations chez CRISPR Therapeutics AG. Au cours de sa carrière, M. Kennedy a occupé les postes de vice-président exécutif chargé de la recherche et du développement chez Mascoma Corp, de vice-président principal et de chef des opérations techniques chez Casebia Therapeutics LLC, de directeur chez Eastman Kodak Co, de directeur de l'exploitation et de vice-président exécutif chez Histogenics Corp, de directeur chez Genencor International, Inc, de vice-président principal chargé des opérations techniques biologiques chez Genzyme Corp et de directeur exécutif du MIT Center au Massachusetts Institute of Technology. Stephen R. Kennedy est titulaire d'un MBA de l'université de Boston, d'un diplôme d'études supérieures de l'université de Rochester et d'un diplôme de premier cycle de l'université du Michigan.
Postes actifs de Stephen Kennedy
| Sociétés | Poste | Début |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Anciens postes connus de Stephen Kennedy
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Chief Operating Officer | 22/03/2019 |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 01/08/2013 |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/05/2011 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2010 |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Corporate Officer/Principal | 01/01/1992 |
Formation de Stephen Kennedy
| Rochester Christian University | Graduate Degree |
| Boston University | Masters Business Admin |
| University of Michigan | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EASTMAN KODAK COMPANY | Producer Manufacturing |
| CRISPR THERAPEUTICS AG | Health Technology |
| Entreprise privées | 7 |
|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Mascoma Corp.
Mascoma Corp. BiotechnologyHealth Technology Mascoma Corp. develops technology for abundant biomass conversion. The firm operates through its bioprocessing technology platform, develops bioengineered yeasts and other microorganisms. It also designs and manufactures equipment that processes cellulosic biomass for further biological or chemical conversion. The company was founded by Lee R. Lynd, Charles E. Wyman and Robert J. Johnsen in 2005 and is headquartered in Waltham, MA. | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Sweet Natural Trading Co. Ltd.
 Sweet Natural Trading Co. Ltd. Food: Specialty/CandyConsumer Non-Durables Sweet Natural Trading Co. Ltd. engages in the provision of consumer-packaged goods with natural sweetener-based products such as xylitol and coconut sugar. It operates through the Canada and United States geographical segments. It offers candies; bread; cereal; snacks; dips and spreads; drinks; condiments, dressing, and sauces; baking products, pasta, and chocolate. The company was founded by Andrew Reid and Julie Reid in 2004 and is headquartered in Toronto, Canada. | Consumer Non-Durables |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
